Clinical trial · Observational
Trastuzumab Deruxtecan in Advanced Breast Cancer
Trastuzumab Deruxtecan in Patients With Advanced Breast Cancer: a Real-world Study
NCT07180264CI-TRIAL-00097379recruitingClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
To evaluate the efficacy and safety of trastuzumab deruxtecan in advanced breast cancer patients.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Advanced Breast Cancer | Malignant Breast Neoplasm | CURATED_BROADER | 0.78 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Trastuzumab deruxtecan | Drug | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- label
- Trastuzumab deruxtecan
- description
- Trastuzumab deruxtecan, recommended dose 5.4mg/kg, every 21 days
- interventionNames
- Drug: Trastuzumab deruxtecan
Primary outcomes (1)
- measure
- Progression-Free Survival (PFS)
- timeFrame
- From the date of starting Disitamab vedotin to the date of first documentation of progression or death (up to approximately 1 years)
- description
- The time from the date of starting trastuzumab deruxtecan to the date of disease progression as per RECIST version 1.1 or death from any cause, whichever occurs first.
Secondary outcomes (1)
- measure
- Adverse events
- timeFrame
- From the date of starting trastuzumab deruxtecan to the end of the treatment (up to approximately 1 year)
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Aged ≥18 and older * Breast cancer patients meeting current guideline recommendations and planning to receive trastuzumab deruxtecan * ECOG 0-1 Exclusion Criteria: * During pregnancy and lactation
References
Publications (0)
Data not yet available
No reference posted for this study.